Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010304 |
---|---|
Receipt number | R000012059 |
Scientific Title | Volunteer study using a newly developed amiloid imaging PET tracer: [18F]FPYBF-2 |
Date of disclosure of the study information | 2013/03/22 |
Last modified on | 2022/10/04 08:26:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/03/22 20:07:07 | ||
2 | Update | 2013/03/22 20:30:05 | Email Category of Funding Organization |
|
3 | Update | 2013/11/14 16:48:27 | Email |
|
4 | Update | 2014/04/03 14:26:02 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
5 | Update | 2014/10/03 09:32:34 | Publication of results Other related information Other related information |
|
6 | Update | 2015/03/03 10:58:08 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results Results |
|
7 | Update | 2015/10/01 14:58:26 | Recruitment status |
|
8 | Update | 2017/07/09 12:01:20 | Name of primary person or sponsor Organization |
|
9 | Update | 2019/01/24 18:10:03 | Last name of lead principal investigator Last name of lead principal investigator Organization Last name of contact person Last name of contact person Organization Name of person sending information Name of person sending information Organization Name of primary person or sponsor Institute Organization Organization Institutions |
|
10 | Update | 2019/02/01 14:03:52 | UMIN ID1 |
|
11 | Update | 2019/02/01 14:32:25 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
12 | Update | 2019/03/27 10:10:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Institute Department Organization Organization Address Address Tel |
|
13 | Update | 2019/03/27 11:46:22 | Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
14 | Update | 2019/03/27 11:59:30 | Date of IRB Other related information Other related information |
|
15 | Update | 2022/10/04 08:26:58 | Narrative objectives1 Key secondary outcomes Key secondary outcomes |